Recently, researches have revealed USP14 enhances cisplatin resistance through affecting Akt/ERK signaling pathways and accelerates cell proliferation and migration in GC (Fu et al., 2018; Han K.H. et al., 2019; Xia et al., 2019). The gene discussed is AKT1; the disease is gastric cancer.